Home  »  Company  »  Marksans Pharma Ltd.  »  Quotes  »  Audited Results
Enter the first few characters of Company and click 'Go'

Audited Results of Marksans Pharma Ltd. Company

(Rs in Cr.) Mar 31, 2016 Mar 31, 2015 Mar 31, 2013 Mar 31, 2012 Mar 31, 2011
Operating Income 358.13 405.59 192.30 154.59 154.70
Manufacturing Expenses 7.11 7.74 4.57 3.84 6.03
Personnel Expenses 26.13 23.65 15.39 13.55 11.38
Selling Expenses 0.00 0.00 0.00 0.00 13.45
Administrative Expenses 42.81 40.31 25.36 167.22 7.61
Expenses Capitalised 0.00 0.00 0.00 0.00 0.00
Cost Of Sales 254.24 289.85 148.03 272.37 146.71
Operating Profit 103.89 115.74 44.27 -117.78 7.99
Other Recurring Income 8.69 3.09 4.17 1.95 1.68
Adjusted PBDIT 112.58 118.83 48.44 -115.82 9.67
Financial Expenses 6.20 13.11 10.13 49.09 105.77
Depreciation 14.75 9.03 8.70 17.98 14.64
Other Write offs 0.00 0.00 0.00 0.01 0.19
Adjusted PBT 91.63 96.68 29.61 -182.90 -110.93
Tax Charges 20.14 29.58 -9.98 -1.84 3.46
Adjusted PAT 71.49 67.11 39.58 -181.07 -114.40
Non Recurring Items 0.00 0.00 0.00 0.00 -102.01
Other Non Cash adjustments 0.00 0.00 0.00 0.00 -1.38
Reported Net Profit 71.49 67.11 39.58 -181.07 -217.79
Equity Dividend 4.61 4.60 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00
Retained Earnings -119.44 -182.95 -294.22 -333.80 -152.73
 
Subscribe now to get personal finance updates in your inbox!